Health Condition 1: B070- Plantar wart
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients (18-60 yrs) with plantar warts attending Dermatology OPD in a tertiary care hospital in western Maharashtra.
Exclusion criteria
Exclusion criteria: 1) Consent Denial. 2) Un-cooperative patients 3) Previous history of hypersensitivity to TCA 4) Known case of HIV/HBsAg/HCV/Diabetes Or Bleeding disorder 5) Patients who have taken treatment for plantar warts in the last one month 6) Age less than 18yrs or more than 60yrs 7)Immunosuppressed patient (On immunosuppressants or daily/pulse steroids)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of topical 40% TCA (trichloroacetic acid) with needling versus needling alone in complete cure/ improvement of the plantar warts. Resolution as defined based on:- Reduction in size and/or number/clearance of the warts as marked by the patient & the dermatologist 1)Complete cure: 100% clearance of warts (return of normal dermatoglyphics) 2)Mild resolution: Upto 50% improvement 3)Moderate resolution: 50-99.9% improvement Timepoint: After 12 weeks of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the time taken for clinical cure/ improvement of the plantar warts 2. To observe for any adverse effects of needling & topical 40% TCA application Timepoint: At 4-weekly intervals and after 12 weeks of therapy | — |
Countries
India
Contacts
Armed Forces Medical College